Study: Rapid treatment boosts survival odds for stroke victims

06/18/2013 | HealthDay News · EverydayHealth.com

A study in the Journal of the American Medical Association showed that the earlier a stroke patient receives clot-dissolving drugs, the better the outcome. Researchers looked at data from more than 58,000 ischemic stroke patients. Patients treated with tissue plasminogen activators within 90 minutes of symptom onset had a 26% lower risk of death and 28% reduced risk of intracranial hemorrhage than those treated within 181 to 270 minutes, for example.

View Full Article in:

HealthDay News · EverydayHealth.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN